|
|
|
|
|
by mdm_
1688 days ago
|
|
>Study authors said the findings suggest vaccinating young children against COVID-19 could also elicit a similar or greater degree of protection than that of adults. >Given similarities in the response to natural infection in children
and adults, it is likely that vaccination against SARS-CoV-2 will also elicit a similar degree of protection
across the full spectrum of age, as has recently been reported for the Pfizer-BioNTech vaccine in children
12–15 years of age (42). Though we cannot directly compare our results to the neutralizing antibody titers
reported in vaccine trial studies, both the vaccine trial data and our results suggest that younger age may be
associated with greater neutralizing antibody responses. I'm not a doctor, but doesn't this actually suggest that the younger the age we can administer COVID-19 vaccines, the stronger the antibody response is likely to be? |
|
We'll only figure out the truth long after it matters, so the question being debated is the risk of complications from the vaccine compared to the risk of complications from COVID. Given younger populations have very, very low risk from COVID, this is a subtle and complicated question to answer.